Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALM: Sertraline for Anxiety in Children and Adolescents With Neurodevelopmental Disorders
NCT06081348Phase 2Recruiting
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Start
- Sep 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sertraline in anxiety disorder, sponsored by Holland Bloorview Kids Rehabilitation Hospital. Started Sep 2024; status: recruiting.
02
Drugs
sertraline
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT06081348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06081348.